SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

FIGRs sustained selloff is driving a bearish debate, with traders pointing to insider and pre-IPO shareholder selling, stock-compensation concerns, and doubts about management. Bulls counter that loan-marketplace growth and the companys tokenization and fintech platform remain compelling, but the stocks persistent weakness is overshadowing that thesis.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is drawing attention as biotech attempts a modest rebound after a sharp sector-wide pullback, with traders watching whether the bounce can extend or gives way to more chop. The discussion ties the ETFs weakness and recovery to rate and yield concerns, risk appetite and sector rotation, while some traders point to M&A chatter and upcoming biotech catalysts as potential supports.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Discussion centers on mixed sales signals: traders point to weakness in the core Celsius brand, with Alani Nu growth providing some offset, and debate what that means for the companys growth outlook. Bulls cite insider buying, Pepsis distribution partnership and international expansion, while frustrated holders question management and the stocks persistently weak, range-bound performance.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

BETRs sharp rally is driving speculation about a potential short squeeze, with traders pointing to the companys share repurchases, limited float, and elevated short interest as possible fuel. The squeeze is unconfirmed, and some traders question whether the move can continue without stronger volume or further execution on the companys turnaround updates.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

A rebound in Nasdaq and technology shares, alongside renewed AI optimism, has lifted TQQQ after a sharp selloff; traders are split between viewing the move as a durable recovery and a temporary relief rally or trap. The community is also discussing heavy inflows into leveraged ETFs, underscoring strong appetite for high-beta tech exposure amid volatility.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is drawing attention ahead of its fiscal fourth-quarter and full-year earnings report, with traders focused on forward guidance and margins as much as the headline results. Bulls point to the stocks recent strength, while others warn that elevated expectations or soft guidance could prompt a pullback.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

A strong rebound in big tech, supported by renewed AI enthusiasm, weighed on SQQQ, the leveraged inverse Nasdaq ETF. Traders are split between buying the dip as a hedge against concerns over AI spending and tech valuations, and cautioning that continued tech strength and the funds daily leverage reset make long positions risky.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos licensing of a Chinese companys experimental oral GLP-1/GIP obesity drug has renewed debate about its strategy as it tries to answer Eli Lillys competition. Many traders question the cost and early stage of the asset and criticize management, while others see the dealand oral Wegovy demandas potential ways to strengthen Novos pipeline; broader sentiment remains cautious after the stocks steep decline.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 topline results from its Phase 3 APPROACH trial of HLP003 for major depressive disorder, with traders focused on the readout as a major binary catalyst. Many are optimistic, citing reported insider buying and the drugs add-on trial design, while others stress the risk of disappointing data and potential dilution.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is drawing attention after a sharp, persistent silver selloff and a break below a major round-number support level. Many traders expect further downside and are shorting, while others see an oversold dip and are adding to positions or buying physical silver.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ceva, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call

Ceva, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Ceva, Inc. Schedules Third Quarter 2026 Earnings Release and Conference CallPR NewswireROCKVILLE, Md., Oct. 14, 2026ROCKVILLE, Md., Oct. 14, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon...

Will AI Expansion Drive CEVA's Shares to Further Heights?

Ceva's LG partnership pairs UWB IP and software with RF technology, targeting faster time to market as global UWB device shipments are projected to surge.

Ceva Appoints Semiconductor Industry Veteran Ziv Hammer as Executive Vice President to Lead Connectivity & Sensing

Ceva Appoints Semiconductor Industry Veteran Ziv Hammer as Executive Vice President to Lead Connectivity & Sensing Ceva Appoints Semiconductor Industry Veteran Ziv Hammer as Executive Vice President to Lead Connectivity & SensingPR NewswireROCKVILLE, Md., Sept. 15, 2026 Former Intel, Infineon and...

CEVA or SNPS: Which Semiconductor Stock Is Worth Buying Now?

SNPS stands out over CEVA as AI-driven EDA growth, recurring revenues, strong cash flow and better price performance strengthen its investment case.

Ceva and LG Electronics Partner to Accelerate UWB Adoption Across Automotive, Industrial and Consumer SoCs

Ceva and LG Electronics Partner to Accelerate UWB Adoption Across Automotive, Industrial and Consumer SoCs Ceva and LG Electronics Partner to Accelerate UWB Adoption Across Automotive, Industrial and Consumer SoCs PR Newswire ROCKVILLE, Md. and SEOUL, South Korea, Sept. 9, 2026 Ceva-Waves UWB...

Analysing CEVA's (CEVA) Growth in Neural Processing Markets

Analysing CEVA's (CEVA) Growth in Neural Processing Markets...

CEVA Stock Slides 19% in a Month: Should You Buy the Dip or Wait?

Ceva has fallen nearly 19% in a month despite Q2 beats and solid growth, but its premium valuation suggests investors may want to wait before buying.


Bears are Losing Control Over Ceva (CEVA), Here's Why It's a 'Buy' Now

Ceva (CEVA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Bull of the Day: Ceva (CEVA)

Brains of the semis that deliver connectivity, sensing, and edge inference is on a "royal" path to profits

CEVA (CEVA) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

CEVA, Inc. engages in the provision of silicon and software intellectual property solutions that enable smart edge products to connect, sense, and infer data. Its products include Ceva-Waves Links, Ceva-Waves Wi-Fi, Ceva-Waves Dragonfly, Ceva-XC23, Ceva-XC21, Ceva-Waves Bluetooth, Ceva-Waves UWB, Ceva-PentaG2, and Ceva-PentaG RAN. The company was founded on November 22, 1999 and is headquartered in Rockville, MD.

Ceva Inc.

Bearish Sentiment

$HOOD (Tuesday afternoon)

$MSFT (Wednesday afternoon)

$GOOGL (Wednesday afternoon)

$AMZN (Thursday afternoon)

Which earnings release are you most excited for this week?

Drop a comment for other tickers.

Current Price	$29.41
Prev Close	$28.62
Open	$28.75
Dividend Yield	0.00%
50-Day Moving Average	$30.40
Beta	2.45
Avg. Volume	694,795.34
PE Ratio	-71.25

52-Week High	$51.60
52-Week Low	$17.02
Market Capitalization	$828.01M
EPS (Annual)	-$0.4379
Price to Book	2.43
Revenue Per Employee	$258,485.85

Feed

News

Sentiment

Earnings

Fundamentals

Info

CEVA Fundamentals